Navigation Links
First Genetic Cure For Cancer Anchors Provocative New Thriller
Date:6/27/2012

Dallas, TX (PRWEB) June 27, 2012

What would happen if a groundbreaking advance in medicine fell into the hands of a desperate Wall Street executive, hell-bent on taking the company public and turning a huge profit… no matter the cost.

In his newest novel, "Genetic Imperfections", author Steve Hadden deftly guides readers through the high-stakes world of pharmaceutical development while telling the story of a father turned bitter over the loss of his young son to cancer. Rexen Labs is sitting on a gold mine. After years of development, the family-owned pharmaceutical company is finally prepared to begin marketing the biggest drug breakthrough since penicillin, a genetic cure for cancer. With Rexen Labs ready to go public, billions of dollars—and a ten-year-old’s life—hang in the balance.

Asked why he wrote "Genetic Imperfections", Hadden said, “I’m intrigued by how the complexity of the human genome stands in the way of the first genetic cure for cancer and how corporate greed can transform the most well intended people.”

The thriller opens fifteen years ago, after David Wellington abandoned his lucrative banking career and joined Rexsen Labs to save his young son's life. But despite his sacrifices and prayers, he helplessly watches him die. On that day his heart hardens and he embarks on a path of cynicism, materialism and self-indulgence. Now, propelled by the pending FDA approval of CGT, the first genetic cure for the leukemia that killed his son, he's on the verge of becoming Newport Beach's newest billionaire.

But as Wellington watches his life crumble around him and the cure become a curse, he finds himself at rock-bottom for the second time. Trapped between the authorities and the company he helped build, he risks everything to give meaning to his second chance at life and his only chance for love.

"Genetic Imperfections" is a story of tragedy, greed, redemption and love, uniquely packaged in the thriller genre. It is available through Amazon, Kindle, Barnes and Noble, Nook, Apple’s iBooks, Smashwords, Diesel and Kobo. Visit SteveHadden.com for a synopsis and additional information.

Keep an eye out for Hadden’s next book, "Swimming Monkeys", set to be released later in the summer. A cross between Jurassic Park and The Da Vinci Code, Swimming Monkeys is a powerful coming-of-age thriller that examines the on-going struggle between science and religion.

About Steve Hadden
Steve Hadden is the author of "The Sunset Conspiracy", "Genetic Imperfections" and The "Swimming Monkeys" Trilogy. Steve was born in Ohio and has lived across the U.S. including stops in Maryland, Indiana, Pennsylvania, Oklahoma, Wyoming, California, Texas, Connecticut and Colorado. He’s traveled around the world and uses his experience and curiosity about the larger issues we face to bring his thrillers to life. Steve lives in Texas with his wife, CJ, and two Labrador retrievers, Emma and Abby. Visit his website at http://www.stevehadden.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9640958.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
2. Nourish the World! Terra Biotech Receives Thanks and Praise After First Shipment of 10,000 Servings of Nectr Core Vitamin Powder to Orphans in Ghana, Africa
3. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
4. NDIA, NTSA Will Be On Hand At Seventh Annual Capitol Hill Modeling and Simulation Expo, Set To Focus On Homeland Security, First Response
5. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
6. ScaleMatrix Leads the Way Unveiling the Industry’s First Transparent Pricing Tool in Private Cloud Offerings
7. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
8. CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device
9. First experiment at the ALBA synchrotron
10. EPSRC announces first recipients of Fellowships in Manufacturing
11. GeneLink Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... N.Y. , Dec. 2, 2016 More than ... (CSHL) 11th Double Helix Medals dinner ( DHMD ). The gala was ... New York City and honored ... their contributions, respectively, to health and medicine and the public ... Ali in 2006, the event has raised $40 million ...
(Date:12/2/2016)... Calif. , Dec. 2, 2016 Amgen (NASDAQ: ... AGN ) today announced the submission of a Marketing Authorization ... 215, a biosimilar candidate to Avastin ® (bevacizumab). The ... submitted to the EMA. "The submission of ... Amgen seeks to expand our oncology portfolio," said Sean ...
(Date:12/2/2016)... Research and Markets has announced the addition of ... to their offering. ... , , An ... is anticipated. Nanotechnology will be applied at all stages of ... applications in clinical trials. Many of the assays based on ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... the value of DNA microarray comparative genomic hybridization (array CGH) for HER2 ... Cancer Symposium. Using molecular test results from tumors with previously documented positive, ...
Breaking Biology Technology:
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe ... announced BioLock , an electrocardiogram (ECG) biosensor ... monitoring, a key IoT asset. The smart system ... a vehicle,s steering wheel and mobile devices to ... touch. As vehicle technology advances, so ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ... Systems) ... largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of an ...
(Date:11/21/2016)...   Neurotechnology , a provider of high-precision ... that the MegaMatcher On Card fingerprint matching algorithm ... NIST Minutiae Interoperability Exchange (MINEX) III ... of the evaluation protocol. The ... fingerprint templates used to establish compliance of template ...
Breaking Biology News(10 mins):